Tag: Dapagliflozin
AstraZeneca’s Dapagliflozin Gets Approval for Chronic Kidney Disease in India
KOCHI:AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today announced that they.
AstraZeneca’s Forxiga Approved in India for Treatment of Patients with Heart Failure
BENGALURU: AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today received the.
AstraZeneca’s Diabetes Drug Shows Significant Benefits in Patients with Heart Failure
MUMBAI: Studies indicate that every 8 th Heart Failure patient in the world is an.
Glenmark Pharmaceuticals Announces Launch of Latest-in-class Diabetes Medicine
KOCHI: Glenmark Pharmaceuticals Ltd (Glenmark), a research-led global integrated pharmaceutical company, today announced the launch of.